Susquehanna International Group, LLP Rigel Pharmaceuticals Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$1.12 - $1.57 $3,360 - $4,710	-3,000 Reduced 0.8%	372,500 $551,000
Q4 2023 Feb 14, 2024	BUY	$0.72 - $1.56 $60,480 - $131,040	84,000 Added 28.82%	375,500 $544,000
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.39 $37,022 - $48,094	-34,600 Reduced 10.61%	291,500 $314,000
Q2 2023 Aug 11, 2023	BUY	$1.12 - $1.82 $180,768 - $293,748	161,400 Added 98.0%	326,100 $420,000
Q1 2023 May 16, 2023	BUY	$1.25 - $2.0 $12,125 - $19,400	9,700 Added 6.26%	164,700 $217,000
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $35,510 - $630,700	53,000 Added 51.96%	155,000 $232,000
Q3 2022 Nov 14, 2022	SELL	$1.1 - $12.2 $440 - $4,880	-400 Reduced 0.39%	102,000 $120,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $19,497 - $92,829	29,100 Added 39.7%	102,400 $116,000
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $163,170 - $253,575	-73,500 Reduced 50.07%	73,300 $219,000
Q3 2021 Nov 15, 2021	SELL	$3.5 - $4.5 $154,700 - $198,900	-44,200 Reduced 23.14%	146,800 $533,000
Q2 2021 Aug 11, 2021	BUY	$3.09 - $4.54 $291,387 - $428,122	94,300 Added 97.52%	191,000 $829,000
Q1 2021 May 17, 2021	SELL	$3.35 - $4.93 $211,385 - $311,083	-63,100 Reduced 39.49%	96,700 $331,000
Q4 2020 Feb 16, 2021	BUY	$2.35 - $3.74 $40,185 - $63,954	17,100 Added 11.98%	159,800 $559,000
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $229,264 - $531,944	128,800 Added 926.62%	142,700 $342,000
Q1 2020 May 15, 2020	SELL	$1.27 - $3.0 $9,906 - $23,400	-7,800 Reduced 35.94%	13,900 $22,000
Q3 2019 Nov 14, 2019	SELL	$1.63 - $2.62 $270,091 - $434,134	-165,700 Reduced 88.42%	21,700 $41,000
Q2 2019 Aug 14, 2019	BUY	$2.02 - $2.61 $35,956 - $46,458	17,800 Added 10.5%	187,400 $489,000
Q1 2019 May 15, 2019	BUY	$2.0 - $2.65 $219,800 - $291,235	109,900 Added 184.09%	169,600 $436,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.59 $153,920 - $212,528	-59,200 Reduced 49.79%	59,700 $192,000
Q2 2018 Aug 14, 2018	SELL	$2.83 - $4.11 $1.75 Million - $2.54 Million	-618,100 Reduced 83.87%	118,900 $336,000
Q1 2018 May 15, 2018	BUY	$3.54 - $4.54 $2.33 Million - $2.98 Million	657,000 Added 821.25%	737,000 $2.61 Million
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $29,393 - $39,130	9,100 Added 12.83%	80,000 $310,000
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $154,562 - $182,213	70,900	70,900 $180,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account